The largest database of trusted experimental protocols

Brdu incorporation elisa assay

Manufactured by Roche
Sourced in Germany

The BrdU incorporation ELISA assay is a laboratory technique used to measure cell proliferation. It detects and quantifies the incorporation of the synthetic thymidine analog bromodeoxyuridine (BrdU) into the DNA of proliferating cells. The assay provides an objective and quantitative measurement of DNA synthesis, which is a direct indicator of cell division and proliferation.

Automatically generated - may contain errors

4 protocols using brdu incorporation elisa assay

1

BrdU Proliferation Assay for MCF-7 and MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was analyzed by the BrdU incorporation ELISA assay following the manufacturing instructions (Roche Diagnostics GmbH, Mannheim, Germany). The incorporation of BrdU into genomic DNA during cell growth was quantified and analyzed after SPGE extract treatment (10–1,000 μg/mL) in our experiments. After the substrate degradation, the color intensity changes were read at 450 nm (reference wavelength: 690 nm) by CytationTM 3 Cell Imaging Multi-Mode Reader (Biotec). The numbers of experimental repeats were set (n = 3). Based on Resazurine and BrdU assays, the final IC50 was calculated and determined: 160 μg/mL (MCF-7 cells) or 130 μg/mL (MDA-MB-231 cells) (Kubatka et al., 2019 (link); Kubatka et al., 2020a (link); Kubatka et al., 2020b (link)).
+ Open protocol
+ Expand
2

Antibody-based Assays for Cell Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study was used: anti-rabbit and anti-goat secondary antibodies as well as polyclonal RIP1, RIP3, Bax and Bcl-2 antibody from Santa Cruz Biotechnology (Santa Cruz, CA); polyclonal LC3 antibody from Abcam; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and RNAse A and 2′,7′-Dichlorofluorescin diacetate (DCF-DA) from Sigma-Aldrich; Annexin V-FITC apoptosis detection kit and propidium iodide staining solution from BD Pharmingen; BrdU incorporation ELISA assay from Roche (Grenzach-Wyhlen, Germany).
+ Open protocol
+ Expand
3

Synthesis and Biological Evaluation of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagents used for the syntheses were of analytical grade and were used without further purification. They were as follows: VO(acac)2 (≥98%, Sigma-Aldrich, Saint Louis, MO, USA), N,N-bis(carboxymethyl)-dl-alanine trisodium salt (Na3bcma) (≥90%, Sigma-Aldrich), N-(Phosphonomethyl)iminodiacetic acid (H4pmida) (95%, Sigma-Aldrich), N-(2-carboxyethyl)iminodiacetic acid (H3ceida) (≥98.0%, VWR) and 4-amino-2-methylquinoline (4-NH2-2-Me(Q), ≥98%, Sigma-Aldrich). In a biological study, it was used anti-rabbit secondary antibodies as well as polyclonal anti-p53 and RAGE antibodies from Santa Cruz Biotechnology (Dallas, TX, USA). Polyclonal anti-cdk1, cyclinB1, p21, β-actin and LC3β antibodies were purchased from Abcam (Cambridge, UK). Anti-rabbit antibodies conjugated with Alexa Fluor546 were obtained from Thermo Fischer Scientific (Waltham, MA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), neutral red (NR), RNAse A, 2′,7′-dichlorofluorescin diacetate (DCF-DA), phalloidin, hoechst, bovine serum albumin (BSA), paraformaldehyde, gemcitabine, and propidium iodide were purchased from Sigma-Aldrich (Saint Louis, MO, USA). BrdU incorporation ELISA assay from Roche (Grenzach-Wyhlen, Germany) and LDH-Cytotoxicity Assay from Promega (Madison, WI, USA).
+ Open protocol
+ Expand
4

HEK 293 Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293 cell proliferation was determined using the BrdU incorporation-ELISA
assay (Roche Applied Science; Mannheim, GE) following manufacturer’s
instructions. Briefly, cells
(10 × 103/well) were
cultured in DMEM supplemented with ghrelin (100 nM) for
12 h and then were incubated with 10 mg/mL BrdU for
12 h before being fixed with FixDenat solution. The fixed cells were
further treated with anti-BrdU-POD working solution, and rinsed with washing
solution before substrate solution was added. The absorbance at
370 nm (reference wavelength at 492 nm) was measured
using an ELISA plate reader (Reader VersaMaxPLUS).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!